Differin Extends With Cleanser, Moisturizer, Bioré Adds Foam In OTC Skin Care
This article was originally published in The Rose Sheet
Executive Summary
Galderma Labs receives FDA approval for new labeling for its OTC Differin acne treatment and launches cleanser and moisturizer under the brand. Kao USA extends its Bioré line with acne cleansing foam and Naturopathix updates packaging for its ZymaDerm homeopathic indicated for molluscum skin infections.
You may also be interested in...
Private-Equity Investors Poised To Acquire Nestlé Skin Health, Promising US Expansion
After working hard to turnaround its troubled Skin Health dermatology operation, Nestlé looks set to offload the business to a consortium of private-equity buyers. The consortium - led by EQT - have identified expansion in the US consumer health market as an immediate priority.
Benzoyl Peroxide Effective On Acne, But No Skin Microbiome Effect – Study
Acne treatment study found set out to better understand the pathogenesis of pre-adolescent acne and the impact of OTC acne drug benzoyl peroxide after an earlier study showed treatment with ingredient significantly decreased alpha diversity on girls' skin.
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.